NCT03080493View on ClinicalTrials.gov

Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

November 5, 2018

Study Completion Date

November 5, 2018

Conditions
Abortion, InducedCervical PreparationPain
Interventions
DRUG

Gabapentin 600mg

Gabapentin 600 mg PO (two total doses, thereby lasting duration while osmotic dilators are in place)

DRUG

Placebo oral capsule

Packaged identical to gabapentin dosing

DRUG

acetaminophen/codeine and ibuprofen

Over the counter analgesic medications

Trial Locations (1)

95817

University of California Davis Health System, Sacramento

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

University of California, Davis

OTHER

NCT03080493 - Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter